| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 23:30 | CME Group completes initial cloud performance testing | ||
| 23:30 | Yiren Digital CEO subject to criminal compulsory measures | ||
| 23:30 | Mizuho raises Viper Energy stock price target on production outlook | ||
| 23:06 | Goldman Sachs cuts StubHub stock price target on valuation reset | ||
| 22:54 | Applied Materials unveils $5 billion chip R&D facility | ||
| 22:54 | Nexxen appoints Neil Jones as interim board chairperson | ||
| 22:54 | Castle Biosciences presents Barrett's esophagus test data at ACG | ||
| 22:54 | Murphy Oil reports offshore discoveries, production starts | ||
| 22:54 | Mueller Water Products names Michael Morgan as new CFO | ||
| 22:54 | Biomea Fusion to report Phase I trial results Tuesday | ||
| 22:54 | Danaher adds two directors, expands board to 13 members | ||
| 22:54 | Medline launches enhanced inventory management system for care facilities | ||
| 22:54 | Global Ship Lease secures $1 billion loan facility at 1.5% margin | ||
| 22:54 | Seadrill secures contracts worth over $514 million for rigs | ||
| 22:30 | J&J's Tremfya shows fistula remission in Crohn's subgroups | ||
| 22:30 | Onto Innovation wins SK hynix award for HBM defect technology | ||
| 22:30 | ImmuCell reports 46% Q3 sales increase to $8.0 million | ||
| 22:30 | International Paper declares quarterly dividend of $0.4625 | ||
| 22:30 | Northern Oil and Gas reports Q3 operations, share buybacks | ||
| 22:30 | Organogenesis announces publication of diabetic foot ulcer trial | ||
| 22:30 | Oncolytics receives cancer immunotherapy patent in multiple countries | ||
| 22:30 | J&J reports three-year tremfya data for Crohn's disease | ||
| 22:30 | Myomo appoints Mary-Katherine McClure as chief commercial officer | ||
| 22:30 | ArriVent doses first patient in ARR-002 ovarian cancer trial | ||
| 22:06 | Intel unveils GPU D-series for AI inference at OCP summit |